Abstract We analysed the GATA binding protein 4 gene, or GATA4, along with the NK2 transcription factor related, locus 5 gene, or NKX2.5, to determine their genetic contribution to 104 sporadic patients in Indonesia with congenitally malformed hearts, 76 cases having atrial septal defect and 28 tetralogy of Fallot. We found only 1 novel mutation of GATA4 in those with atrial septal defecst. Analysis of the genetic background of the parents of the patient showed for the first time that a new mutation of GATA4 can cause sporadic atrial septal defects. We failed to discover any other mutations of either the GATA4 or NKX2-5 genes, supporting the marked genetic heterogeneity of human congenital cardiac defects.
C ONGENITAL CARDIAC DISEASE IS ONE OF THE
commonest defects found at birth, being observed in more than 1 of each 100 live births. 1 Among these lesions, atrial septal defect and tetralogy of Fallot account for approximately one-tenth and one-twentieth of the overall defects, respectively. Genetic factors have been associated with both lesions. Mutations of GATA4 were found mostly in familial examples of atrial septal defect, [2] [3] [4] [5] [6] [7] [8] [9] but never in these lesions when occurring sporadically. Mutations of NKX2-5 were also observed in a spectrum of both familial and sporadic occurrences of congenitally malformed hearts, including those with atrial septal defect and tetralogy of Fallot, frequently in association with abnormalities of atrioventricular conduction. [10] [11] [12] [13] [14] [15] [16] [17] In this study, we sequenced GATA4 and NKX2-5 to determine their genetic contribution to the occurrence of sporadic congenital cardiac defects in Indonesia, producing what is, to the best of our knowledge, the first evidence of a new mutation of GATA4 causing an atrial septal defect.
Materials and methods
We recruited 76 patients with atrial septal defects located within the oval fossa, and 28 patients with tetralogy of Fallot. In Table 1 , we list the cardiac phenotypes. All patients were non-syndromic, and had been diagnosed on the basis of echocardiography and other standard methods by one of coauthors (S.E.R.) working at Hasan Sadikin General Hospital in Bandung, Indonesia. As established by taking a careful history, we confirmed that none of the parents possessed an abnormal cardiac phenotype. Informed consent was obtained from all the participating families. As normal controls were unavailable for the Indonesian population, we used normal Japanese controls to observe polymorphisms, recognizing that Indonesian and Japanese populations are ethnically unrelated. Experimental protocols were approved by the institutional review board in Yokohama city university school of medicine.
Genomic deoxyribonucleic acid, or DNA, was extracted from peripheral leukocytes using FlexiGene Blood DNA kit (Qiagen, Tokyo, Japan). Whole genome amplification was performed wtih Illustra GenomiPhi V2 DNA Amplification Kit (GE Healthcare Bio-Science, Tokyo, Japan).
We analysed 6 coding exons of GATA4, and 2 exons of NKX2-5, along with their flanking intronic regions. All primers were designed using the webbased Primer3 software (http://frodo.wi.mit.edu/cgibin/primer3/primer3_www.cgi). Detailed information of primers is available on request. Polymerase chain reaction was cycled 35 times at 948C for 30 sec, at 58-648C for 30 sec and at 728C for 30 sec in a total volume of 20 ml containing 30 ng of whole genome amplification deoxyribonucleic acid, and/or genomic deoxyribonucleic acid, as a template, 0.5 mM of forward and reverse primers, 200 mM of each deoxynucleotide triphosphates, and 0.5 Unit of ExTaq (Takara, Ohtsu, Japan) or LATaq (Takara, Japan), purified with ExoSAP-IT (United States Biochemical, Cleveland, OH), and sequenced using BigDye Terminator ver.3.1 (Applied Biosystems, Foster City, CA) on the 3100 Genetic Analyzer (Applied Biosystems). Deoxyribonucleic acid sequences were compared with the reference genome sequences based on the University of California, Santa Cruz Genome Browser (May 2006 assembly) using the SeqScape software Ver.2.1 (Applied Biosystems). All the nucleotide changes found in whole genome amplification deoxyribonucleic acids were also confirmed by sequencing using original genomic deoxyribonucleic acids. Regarding polymorphisms, normal control deoxyribonucleic acids were sequenced until the change was seen, needing up to 96 normal chromosomes.
Results and discussion
A heterozygous mutation of GATA4, specifically c.341_342insA (p.T114TfsX95), was identified in 1 of the patients (Fig. 1) . Analysis of his parental deoxyribonucleic acid confirmed the novel nature of the mutation. Parentage was confirmed by microsatellite analyses. The patient was a 4-year-old boy, Cardiology in the Young presenting because of failure to thrive and recurrent respiratory infections. Echocardiography revealed a hole of 1.4 centimeters diameter in the floor of the oval fossa, as well as pulmonary hypertension. At the age of 4 1/2 years, the defect was closed by insertion of an Amplatzer septal occluder. He is now in a good condition. His healthy 30-year-old father, and 20-year-old mother, were not consanguineous. The pregnancy had been uneventful, and his elder brother, aged 6 years, is also healthy, without any cardiac or other abnormalities (Fig. 1) .
The mutation, c.341_342insA, is the third protein truncation mutation of GATA4, resulting in much earlier termination than the other two, c.1074delC and c.1075delG, thus far reported. 2, 3, 5 All the reported truncations have been found in patients with atrial septal defects. Missense mutations are associated with varied phenotypes, including atrial septal defect, tetralogy of Fallot, atrioventricular septal defect, and ventricular septal defect. 2, [4] [5] [6] [7] 9, 18 . Three inframe changes, specifically p.S46del, p.A118_A119insA, and p.A125_A126in sAA, have also been found in patients with ventricular septal defect and tetralogy of Fallot. 18 Mutations of GATA4 mutations have been reported to be very rare in patients with sporadic congenital cardiac lesions, with an estimated prevalence of less than 1%, 8, 9, [18] [19] [20] this fitting well with our own finding. We also found 5 other SNPs, including rs1062245 in GATA4, as judged by normal control studies or according to the database of single nucleotide polymorphisms (http://www.ncbi.nlm. nih.gov/sites/entrez) ( Table 2 ). GATA4, a central zinc finger transcription factor for cardiac development, binds specifically to the A/T GATA A/G motif on the deoxyribonucleic acid, and modulates transcription of downstream target genes.
9 GATA4 can also physically interact with NKX2-5 21 and TBX5, 2 producing familial congenital heart defects 12 as well as the well recognized Holt-Oram syndrome, which consists of cardiac septal defects, abnormalities of conduction, and skeletal anomalies of the limbs. 22, 23 The previously reported mutation, c.1075delG, failed to activate transcription of downstream genes. 2 Thus mutational consequences of the c.341_342insA found in this study could be similar to c.1075delG as c.341_342insA, and may potentially produce a much shorter protein than c.1075delG, even if its transcript escapes the nonsense mediated decay (Fig. 1) .
None of our patients presented with any pathological changes in NKX2.5, albeit that 5 polymorphisms have been identified in this gene (Table 2) . Approximately one-twentieth of examples of both atrial septal defect and tetralogy of Fallot may be caused by such mutations. 11 The fact that none of our patients exhibited such abnormalities is further evidence supporting the notion that sporadic examples of congenital cardiac disease are genetically heterogeneous. Our analysis of 104 patients with sporadic forms of atrial septal defect and tetralogy of Fallot, therefore, for mutations of the GATA4 and NKX2-5 genes has revealed a new mutation of GATA4 in 1 patient with an atrial septal defect. As far as we are aware, this is the first direct link of such a new mutation demonstrated using genomic deoxyribonucleic acids. Hamanoue et al: Mutation of GATA4 in sporadic atrial septal defect 3
